Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sulfated polyanions do not inhibit duck hepatitis B virus infection.

Literature DB >> 1804020

Sulfated polyanions do not inhibit duck hepatitis B virus infection.

W B Offensperger¹, S Offensperger, E Walter, H E Blum, W Gerok.

Abstract

On the basis of the antiviral action of sulfated polyanions in human immunodeficiency virus and other viral infections, we studied the effect of dextran sulfate and heparin on duck hepatitis B virus infection. These agents do not affect viral uptake and replication in liver cells in vitro or in vivo. Sulfated polyanions, therefore, appear to have no potential for the treatment of hepadnavirus infections.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1991 PMID： 1804020 PMCID： PMC245399 DOI： 10.1128/AAC.35.11.2431

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

27 in total

1. Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine.

Authors: R Ueno; S Kuno
Journal: Lancet Date: 1987-06-13 Impact factor: 79.321

2. Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing.

Authors: I Fourel; P Gripon; O Hantz; L Cova; V Lambert; C Jacquet; K Watanabe; J Fox; C Guillouzo; C Trepo
Journal: Hepatology Date: 1989-08 Impact factor: 17.425

3. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.

Authors: M Ito; M Baba; A Sato; R Pauwels; E De Clercq; S Shigeta
Journal: Antiviral Res Date: 1987-07 Impact factor: 5.970

4. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.

Authors: B Lee; W X Luo; S Suzuki; M J Robins; D L Tyrrell
Journal: Antimicrob Agents Chemother Date: 1989-03 Impact factor: 5.191

5. Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors: D I Abrams; S Kuno; R Wong; K Jeffords; M Nash; J B Molaghan; R Gorter; R Ueno
Journal: Ann Intern Med Date: 1989-02-01 Impact factor: 25.391

6. Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides.

Authors: S Suzuki; B Lee; W Luo; D Tovell; M J Robins; D L Tyrrell
Journal: Biochem Biophys Res Commun Date: 1988-11-15 Impact factor: 3.575

7. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.

Authors: G Civitico; Y Y Wang; C Luscombe; N Bishop; G Tachedjian; I Gust; S Locarnini
Journal: J Med Virol Date: 1990-06 Impact factor: 2.327

8. Application of mathematical model to experimental chemotherapy of fatal murine pneumonia.

Authors: T Hishikawa; T Kusunoki; K Tsuchiya; Y Uzuka; T Sakamoto; T Nagatake; K Matsumoto
Journal: Antimicrob Agents Chemother Date: 1990-02 Impact factor: 5.191

9. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.

Authors: S Lederman; R Gulick; L Chess
Journal: J Immunol Date: 1989-08-15 Impact factor: 5.422

10. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.

Authors: M Baba; R Pauwels; J Balzarini; J Arnout; J Desmyter; E De Clercq
Journal: Proc Natl Acad Sci U S A Date: 1988-08 Impact factor: 11.205

4 in total

4. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.

Authors: W B Offensperger; S Offensperger; E Walter; K Teubner; G Igloi; H E Blum; W Gerok
Journal: EMBO J Date: 1993-03 Impact factor: 11.598